Global Life Science Instrumentation Market to Reach $79.8 Billion by 2027 at a CAGR of 4.8% - ResearchAndMarkets.com

In the changed post COVID-19 business landscape, the global market for Life Science Instrumentation estimated at US$58.2 Billion in the year 2020, is projected to reach a revised size of US$79.8 Billion by 2027, growing at a CAGR of 4.6% over the analysis period 2020-2027.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Friday, December 2, 2022
Information
Tags: 
Technology, Science, Other Science, Other Technology, Chromatography, Growth, PCR, COVID-19, Pet
Geotags: 
CANADA, JAPAN, EUROPE, USA, GERMANY, US, CHINA
Organisation: 
RESEARCH AND MARKETS
Summary
Key Points: 
  • In the changed post COVID-19 business landscape, the global market for Life Science Instrumentation estimated at US$58.2 Billion in the year 2020, is projected to reach a revised size of US$79.8 Billion by 2027, growing at a CAGR of 4.6% over the analysis period 2020-2027.
  • Spectroscopy, one of the segments analyzed in the report, is projected to record a 4.8% CAGR and reach US$19.2 Billion by the end of the analysis period.
  • The U.S. Market is Estimated at $16.9 Billion, While China is Forecast to Grow at 4.2% CAGR
    The Life Science Instrumentation market in the U.S. is estimated at US$16.9 Billion in the year 2020.
  • China, the world's second largest economy, is forecast to reach a projected market size of US$14.1 Billion by the year 2027 trailing a CAGR of 4.2% over the analysis period 2020 to 2027.


The "Life Science Instrumentation: Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

Global Life Science Instrumentation Market to Reach $79.8 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Life Science Instrumentation estimated at US$58.2 Billion in the year 2020, is projected to reach a revised size of US$79.8 Billion by 2027, growing at a CAGR of 4.6% over the analysis period 2020-2027. Spectroscopy, one of the segments analyzed in the report, is projected to record a 4.8% CAGR and reach US$19.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Chromatography segment is readjusted to a revised 5.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $16.9 Billion, While China is Forecast to Grow at 4.2% CAGR

The Life Science Instrumentation market in the U.S. is estimated at US$16.9 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$14.1 Billion by the year 2027 trailing a CAGR of 4.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4% and 3.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

PCR Segment to Record 5.8% CAGR

In the global PCR segment, USA, Canada, Japan, China and Europe will drive the 5.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$6.6 Billion in the year 2020 will reach a projected size of US$9.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 44 Featured) -

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • Bruker Corporation
  • ChromaCode
  • Danaher Corporation
  • Eppendorf AG
  • GE Healthcare
  • Hitachi High-Tech Corporation

What's New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Life Science Instrumentation - Global Key Competitors Percentage Market Share in 2020 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2020 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

Companies Mentioned

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • Bruker Corporation
  • ChromaCode
  • Danaher Corporation
  • Eppendorf AG
  • GE Healthcare
  • Hitachi High-Tech Corporation

For more information about this report visit https://www.researchandmarkets.com/r/vjo716

Copyright: 
Copyright Business Wire 2022